Clinical Trials Logo

Clinical Trial Summary

A patient group receiving a novel cardioplegic formula with MPS ® (Myocardial protection system) and using the MiECC (Minimal extracorporeal circulation system) when undergoing coronary artery bypass grafting is compared to a retrospective patient group undergoing Off-pump coronary artery bypass grafting.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Complication of Coronary Artery Bypass Graft
  • Complication of Extracorporeal Circulation

NCT number NCT03609723
Study type Observational
Source University Hospital, Basel, Switzerland
Contact
Status Completed
Phase
Start date June 12, 2010
Completion date December 31, 2018

See also
  Status Clinical Trial Phase
Completed NCT01698372 - Negative Pressure Dressing After Saphenous Vein Harvest Phase 1
Completed NCT02814084 - Prevena Incision Management N/A
Not yet recruiting NCT02554305 - The Fusion Versus The Affinity Oxygenation Systems N/A
Not yet recruiting NCT01457859 - Effectiveness of Triclosan Coated Sutures in Preventing Leg Wound Infection After Coronary Artery Bypass Surgery Phase 4
Withdrawn NCT02035163 - Atrial Fibrillation Prevention in Post Coronary Artery Bypass Graft Surgery With Cryoablation for Ganglionic Plexi N/A
Completed NCT03612388 - Combined Use of a Novel Cardioplegic Formula With Myocardial Protection System (MPS)® Versus Cardioplexol ® in Isolated Coronary Artery Bypass Grafting (CABG) Using MiECC;
Recruiting NCT02711124 - Relationship Between Level of Hemoglonin A1c and Platelet Function in Patients Undergoing Cardiac Surgery N/A
Completed NCT01406483 - Platelet Reactivity in Patients on a Thienopyridine and Awaiting Coronary Artery Bypass Grafting N/A